Scandion Oncology Newsletter 21st January, 2020
CEO Nils Brünner and Chairman of the Board Peter Høngaard, have now safely returned from the JP Morgan Meeting in San Francisco. The JP Morgan meeting is the largest meeting in the world when it comes to meeting potential partners within Life Science. Prior to the meeting, Scandion Oncology had arranged face-to-face meetings with pharma companies, investors, bankers and service providers.It was a great satisfaction to us that the pharma companies acknowledge the view that we are in heavy need of new drugs to combat anti-cancer drug resistance. Although drugs used in immune-oncology have